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To assess the efficacy and safety of postoperative anal- of operation and the patient's analgesic need. In the ma-
gesia with continuous epidural sufentanil and bupiva- jority of patients, adequate pain relief was obtained at
caine, we performed a prospective study in 614 patients rest and during movement. Late respiratory depression
undergoing major surgery. Before surgical incision, all was observed in three patients; in most patients only
patients received an initial dose of 50 jiig sufentanil in minor side effects were seen. Technical complications
6-10 mL bupivacaine 0.125% via a lumbar or thoracic during epidural puncture or insertion of the catheter
catheter. After 1 h, a continuous infusion was started were4%and3%, respectively. We conclude that contin-
with 50 jag sufentanil in 50 mL bupivacaine 0.125% at a uous epidural sufentanil and bupivacaine is safe and
rate of 6-10 mL/h. The infusion was continued postop- effective, 
eratively for 1-5 days or longer, depending on the type (Anesth Analg 1996;82:754-9)
orphine was the first opioid used epidurally Since 1987 we have used continuous epidural infu-
for postoperative pain relief, but it soon be- sion with sufentanil and bupivacaine 0.125% for peri-
came apparent that its hydrophilic properties operative pain relief after major surgery. To assess the
could lead to severe side effects, especially respiratory efficacy and safety of this pain regimen, a prospective
depression (1). Thus, the application of continuous study was performed in 614 patients during a period
epidural analgesia on surgical wards has been contro­
versial for a long time (2-4). Large studies showed an 
incidence of 0.1 %—1 % of respiratory depression (1-7). 
To reduce this incidence, more lipophilic opioids were 
studied, such as fentanyl (1) and sufentanil, sufentanil 
being the most lipophilic, with a fast onset and theo­
retically a lower risk of late respiratory depression (8).
An alternative is to add a local anesthetic at a low 
concentration. This has two advantages: First, the ad-
of 1-5 days or longer on the surgical ward.
Methods
This study was conducted during a period of 2 yr and 
3 mo (1991-1993) after the approval of institutional 
review board and after obtaining written, informed 
consent. Patients scheduled for elective major surgery 
were admitted to the study. Patients with coagulation
ditive effect leads to a smaller dose of each drug and disorders or patients who refused insertion of an 
thus decreases dose-dependent side effects. Second, epidural catheter were excluded. Concurrent admin- 
several studies indicate that a combination of an opi- istration of low-dose heparin subcutaneously or intra- 
oid and a local anesthetic at a low concentration operative use of intravenous heparin after catheter
insertion were not considered as contraindications.
were premedicated with midazolam, 
0.1 mg/kg orally, 1 li before induction of anesthesia. 
Glucose 2.5%/NaCl 0.9%, 500 mL, was given and 
epidural puncture was performed with an 18-gauge 
Tuohy needle in the thoracic or the lumbar region, 
depending on the site of operation. For the thoracic 
puncture the paramedian approach was used and the
drop technique; in the lumbar region the 
midline approach with "loss of resistence" technique. 
A 20-gauge catheter was inserted cephalad 4 -6  cm 
into the epidural space and tested with 3 mL lidocaine 
2% and adrenaline '1:200,000 to exclude intra vascular
provides better analgesia than either drug alone (9 
12), especially in treating postope 
coughing and mobilization (11,12).
Although early respiratory 
documented after a single dose or du /xg ep 
sufentanil (8), data are lacking on efficacy and safety 
in patients treated with continuous epidural infusion 
of sufentanil and bupivacaine on the surgical ward.
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oi intrathecal position of the catheter. Technical coin- Table 1. Type of Surgery and Level of Catheter Insertion 
plications in relation to epidural puncture or insertion
No. of patients
General anesthesia was induced with thiopental
4 - 6  mir
m g/ kg
0.2-0.4 jtxg/kg vecuro-
was maintained with  
oxygen, 0.33%) and
inspiratory concentration. 
fxg in 10 mL bupivaeaine 0.125% was
s inserted to
: 15 min
incision was begun. One hour after the epidural bolus
was started, consisting 
ntanil in 50 mL bupivaeaine 0.125% at a
Type of surgery
Upper abdominal 351
Midabdominal 66
Lower abdominal 70
Thoracoabdominal 30
Thoracotomy 10
Orthopedic surgery 34
Peripheral vascular surgery 33
Amputation 20
Level of catheter insertion
Thoracic 420 (68%)
Lumbar 194 (32%)
rate of 6 innnri /h
traeheas were extubaled if
higher than 36C)C and if
In the recovery room, the epidural infusion was 
continued at the same infusion rate. If the patient 
indicated moderate or severe pain at rest or during 
movement, a bolus dose of the solution was given  
with the same amount as the infusion rate; the infu­
sion rate was increased by 1-2 m L /h. If pain persisted, 
this procedure was repeated after 30 min and com-
of surgery, the patients' needs of the individual patient, the epidural infu-
temperature was si° n rate w as decreased by 1-2 mL * h • day-1 and 
were cardiovascularly discontinued if the patient indicated no or mild pain
at a low  infusion rate (^ 2  m L /h).
Data are expressed as mean ± sd. VRS and VAS 
scores for different types of surgery were analyzed 
with the ^  test. A P value less than 0.05 was consid­
ered statistically significant.
Results
bined with a paracetamol suppository 1 g every 6 h. If The mean age of the patients was 57 ± 16 yr (range,
30 -60  min, the epidural catheter 
was considered nonfunctioning and removed. Anal-
Most
More male
UL 'Mfln
by intramuscular injection of female patients were involved in the study. Type of
the ward, pain treatment was the same as shown
in » recovery room
m
Mental 
?art rate
was performed by the sur- Table 1.
Analgesia
m
catheter, a
pressure, and 
every 3 h. If the anesthesi- 
the position of the epidural 
dose with bupivaeaine 0.25% was
severe pain at rest or 
an infusion rate S: '12 m L /h,
to a bolus dose of bupivaeaine
0.25%, e o n c
was rncr
eacy 
SC alt;
r
bupivaeaine in the
to 0.2% or 0.25%. The effi-
by a verbal rating
Pain relief at rest was adequate (VRS good or excel­
lent) in 92%-97% of the patients evaluated (Fig. 1). 
Pain relief during movement was adequate in 68% of 
the patients on the first postoperative day, increasing
to 73%~80% on Days 2-5 (Fig. 2). The VAS scores were 
similar to the VRS scores: VAS was ^3 at rest in 
-94% of the patients and <3 during movement in
n t • i r a n « '«  f \  •Pt* !'**  im w t 3-\j f
jjiuu.UJt 1) during the next 5 postop-
re-
2 ;
days or 
in situ.
we added the visual analog scale (VAS; 0 
free and 10 = the worst pain imaginable) to assess
studied 190 patients,
-70% of the patients (Fig. 3).
Type of Surgery
We found no significant differences in VRS nor VAi 
scores after upper abdominal or lower abdominal sur
lower limb
The efficacy of pain a t
m edical student 
morning at
and during
as drow siness, 
were assessed by a
iere were 
movement
:s were e n
Days 1 through 5.
Respiratory Depression
In three patients, respiratory depression occurred on
w  — tm . 4  1
or severe
depending on the type of
2 or 3 days, the second, third, and fourth postoperative days, re-
and the analgesic unknown
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11 h. The infusion rate was increased from 10 to
12 mL/h. The next day he was drowsy and therefore 
the dose was reduced to 10 mL/h. On the morning of 
Day 2 the patient was not arousable and gasping. His 
trachea was intubated and he was ventilated. Nalox­
one 0.16 mg IV was given and spontaneous respiration 
reoccurred. On the intensive care unit, another dose 
of naloxone was given and he was tracheally extu- 
bated 30 min after intubation. Further recovery was 
tine ventful.
Case 2. Patient 376, who had chronic obstructive 
pulmonary disease, received 8 mL/h of the epidural 
solution and had excellent pain relief. On the third 
day she became drowsy with a respiratory rate of 
10 breaths/min. She was transported to the recovery 
room and the epidural medication was discontinued. 
Further recovery was uneventful and the next day she 
returned to the surgical ward.
Case 3. Patient 579 had excellent analgesia with 
8 mL/h during the first 3 postoperative days. The 
epidural medication was discontinued by the surgeon, 
but after a few hours he had severe pain. The visiting 
anesthesiologist restarted the epidural infusion with 
8 mL/h after a bolus dose of 6 mL bupivaeaine 0.25% 
with good result. During the night chlorpromazine 
was given for unknown reasons. Gradually the patient 
became drowsy. In the morning he was mobilized, 
but he became increasingly drowsy, had speech dis­
turbances and had a slow respiratory rate (2-4 
breaths/min). Naloxone 0.6 mg IV was administered. 
The patient was transported to the recovery room. 
Further recovery was uneventful and the patient was
F ig u r e  2, Verbal rating scale: patients with adequate pain relief sent to the ward during the afternoon.
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M inor Side Effects
Itching occurred in a mild degree in 15% of the pa­
tients (Table 3). Motor block occurred only in patients 
with a lumbar epidural catheter. Numbness of the legs 
occurred in patients with a lumbar catheter or a cath­
eter in the lower thoracic region, i.e., T9-12. One pa­
tient experienced speech and visual disturbances on 
the first postoperative day, suggesting central nervous 
system toxicity by bupivaeaine. After the dose was 
reduced from 10 to 8 mL/h, the symptoms disap­
peared. The incidence of urinary retention could not 
be evaluated because all patients had an indwelling 
catheter during epidural treatment.
reasons on the second postoperative day. Retrospec- Technical Complications
tively , w e  can neither prove nor refute the contribu- Complications due to epidural puncture were a
tion o f  epidural treatment.
C a se  1 . Patient 362 had lialoperidol as comedica
bloody tap in 13 patients (2.0%) and inadvertent dural 
puncture in 12 patients (2.0%). Postdural puncture
tion. O n  the day of surgery he received three top-ups, headache occurred in 2 patients.
twice w ith  5 mL bupivaeaine 0.25% and once with Complications due to the insertion of the epidural
5 mL- o f  the solution of the infusion, over a period of catheter were the appearance of blood in the catheter
ANHSTH ANALG
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Table 2. Patients with Respiratory Depression: Characteristics and Outcome
Age (yr) 
ASA class
Puncture site
Top-up doses 
Comedication
Onset (days after
362
60
III
Hemicolectomy
T8-9 
10 mL/h
Haloperidol 2.5 mg IM
2
Naloxone 0.16 mg IV 
Fully recovered
fr* tm  i» t iiw r ^ » * (i|| »«  mi Kiw mm »'■
Patient No. 
376
71
III
Abdominal aorta
9 h 
T6-7 
8 mL/h
Bronchodilators"
3
Epidural discontinued 
Fully recovered
IM ~
“ Budcsonido 1 mg, 2 times; salbutamol 400 /u-g, 4 times; ipratropium 500 /xg, 4 times.
579
72
III
Abdominal aorta
2.5 h 
T7-8 
8 mL/h 
1
Chlorproniazine 25 mg IM
4
Naloxone 0.6 mg IV 
Fully recovered
Table 3. Side Effects of Continuous Epidural Infusion, with Sufentanil and Bupivacaine
«» » H  ij I
Day
Side effects (% of patients) 0" (n = 435) 1 (n = 529) 2 (n = 456) 3 (11 = 344) 4 (n = 244) 5 (n = 152)
Drowsiness 5.0 20.2 15.1 10.3 6.1 4.5
Respiratory depression 0 0 0.4 0.2 0.3 0
Itching 3.9 14.8 14.9 12.1 7.6 4.5
Nausea 3.9 7.8 5.9 4.2 3.5 3.3
Lower limb weakness 3.9 6.5 4.7 3.7 2.6 1.6
Numbness of the lower limbs 3.9 10.9 7.9 5.3 4.9 2.9
Hypotension*’ 2.0 1.0 0.4 0 0 0
n ; No. of patients.
" One hundred fifty-four patients went to the intensive care unit for postoperative mechanical ventilation and, therefore, could not be evaluated on Day 0. 
h More than 20% decrease of the mean arterial pressure compared to the preoperative value or systolic blood pressure less than 100 mm Hg.
in 18 patients (2.8%). In 2 patients (0.3%) the catheter and went to the surgical ward on the following morn-
to be in the subarachnoid space and the ing where they could be further evaluated. In 49 pa­
tients (8%) the epidural catheter was removed because 
of inadequate analgesia despite top-up doses and in­
creasing the infusion rate. In 52 patients the epidural 
catheter migrated outward.
epidural technique was abandoned.
‘SC
The mean duration was 4.2 ± 3.2 days. In 152 patients 
(25%) the epidural catheter remained in place for more 
than 5 days. The maximum duration of treatment was 
46 days in a patient with cancer pain. There were no 
clinical signs of i 
was
The total of treatment days
The number of 
•iy of surgery
decreased from 614 on the
tients inadvertent durai puncture occurred, in 2 pa­
tients the epidural catheter appeared to be in the sub­
arachnoid space, in 6 patients the epidural catheter
few
three catheters migrated
were
la ted on the intensive care unit postoperatively and
could not be evaluated Most
were
Mean Dose
was 2.8 mL/h  
; 2.6 mL/h or
administered
ts received two
60 pa-
and 11 patients received more than two 
Most top-up doses were administered <
had to be excluded on the day of surgery; in 12 pa- surgery
i n
creased to 0.2% or 0.25% to obtain adequate pain relief. 
Five of these patients were treated for pain after ampu­
tation. Three patients underwent laparotomy.
Discussion
In this study the regimen of a continuous epidural 
infusion of 50 jug sufentanil in 50 mL bupivacaine
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0.125% at a rate of 6—10 mL/h during five consecutive 
postoperative days provided adequate pain relief in 
the majority of patients after major surgery.
In most studies, the efficacy of pain relief is only 
assessed in patients at rest. Recent studies have fo­
cused on pain relief during mobilization and coughing 
(11-15). Two studies (11,12) demonstrated that post­
operative analgesia by an opioid-bupivacaine combi­
nation was significantly better during mobilization 
and coughing than by an epidural opioid alone.
caine had to be increased.
Early respiratory depression, i.e., within five to 10 
minutes after epidural administration of sufentanil, 
has been described after a bolus dose of 50 jug (8). To 
our knowledge, no prospective study is available ad­
dressing the incidence of clinical symptoms of respi­
ratory depression in a large number of patients after 
continuoLis infusion of sufentanil or sufentanil and a 
local anesthetic. Hasenbos et al. (13) compared contin­
uous epidural sufentanil and bupivacaine with nico- 
morphine and bupivacaine for postoperative analge- 
sia after thoracic surgery. They found an increase of 
the Paco2 on the day of surgery in two groups of 
20 patients each, but there were no clinical symptoms 
of respiratory depression requiring the administration 
of naloxone. The mean plasma sufentanil concentra­
tions gradually increased during the first three post­
operative days. This might explain the late and insid­
ious onset of the respiratory depression that we 
observed in three patients. Although we expected epi­
dural sufentanil to be safer than epidural morphine, 
the incidence of respiratory depression appeared to be 
the same. Contributing risk factors are advanced age, 
high doses of opioids, concomitant use of systemic 
opioids or neuroleptic drugs, thoracic administration, 
impaired respiratory function, ASA class III and 
higher, major and prolonged surgery, and positive 
pressure ventilation (1,2,5). In our patients, four to six 
risk factors could be detected (Table 2).
Of the minor side effects, drowsiness occurred most 
frequently on the first postoperative day. Most pa­
tients did not find that bothersome. Itching, not spon­
taneously mentioned by most patients, was of a mild 
nature and diminished after two or three days. Itching 
is found in 11 % of patients receiving epidural or spinal 
morphine (6); an incidence of even 40%-100% has 
been reported (8,19). In this study only one patient 
experienced severe itching, with no response to nal­
oxone. Nausea occLirred in 8% of the patients. Since 
most operations were in the abdominal region, this 
number is surprisingly low. Effective pain relief may 
possibly influence the incidence of nausea (6), since 
pain can cause nausea.
There is still controversy regarding the optimal epi­
dural puncture site. Some studies show only marginal 
benefits of thoracic administration of fentanyl or 
sufentanil compared to lumbar injection (20,21). Oth­
ers found more reliable analgesia (22) and better pul­
monary function, lower incidence of nausea or seda­
tion, shorter time to first bowel movement, and earlier 
discharge from the hospital (14) after thoracic admin­
istration. We believe that it is important to choose the 
epidural puncture site at a level appropriate to the 
innervation of the surgical incision, because the ad­
ministration of sufentanil, which is highly lipophilic, 
results in segmental analgesia. Indeed, Boersma et al.
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(23) have shown, in postmortem studies, that the larg­
est concentration of sufentanil can be found near the 
tip of the epidural catheter.
With respect to the local anesthetic, it is equally 
important to choose the correct puncture site for op­
timal spread of the sensory blockade. We found, ret­
rospectively, that in 15 of 49 patients with inadequate 
analgesia the insertion level of the catheter was incor­
rect: The catheters were inserted at the lumbar level 
for upper- and mid-abdominal surgery. In m ost of 
these patients the catheters were removed  
turely. Inadequate analgesia may result in a tendency 
to increase the infusion rate in an attempt to overcome 
this problem. As a result the incidence of side effects, 
notably respiratory depression, may increase. We rec­
ommend standardization of the epidural treatment 
according to a protocol. If the study solution is used, 
we advise limiting the epidural infusion rate to 10 
mL/h in thoracic administration and to 15 m L /h  in
4. De Leon-Casasola OA, Parker B, Lema MJ, et al. Postoperative 
epidural bupivacaine-morphine therapy. Experience with 4227 
surgical cancer patients. Anesthesiology 1994;81:368-75.
5. Gustafsson LL, Schildt B, Jacobsen K. Adverse effects of extra­
dural and intrathecal opiates: report of a nationwide survey in 
Sweden. Br J Anaesth 1982;54:479 -86.
6. Stenseth R, Sellevold O, Breivik H. Epidural morphine for post­
operative pain: experience with 1085 patients. Acta Anaesthesiol
Scand 1985;29:148-56.
7. Rawal N, Arner S, Gustafsson LL, Allvin R. Present state of 
extradural and intrathecal opioid analgesia in Sweden. A na­
tionwide follow-up survey. Br J Anaesth '1987;59:791-9.
8. Grass JA. Review article. Sufentanil: clinical use as postopera-
route. Pain Symptomlive analgesic 
Manage 1992;7:271-85.
9. George KA, Chisakuta AM, Gamble JAS, Browne GA, Thoracic 
epidural infusion for postoperative pain relief following abdom­
inal aortic surgery: bupivacaine, fentanyl or a mixture of both? 
A n aes thes ia 1992;47:388 -94.
10. Cooper DW, Turner G. Patient-controlled extradural analgesia 
to compare bupivacaine, fentanyl and bupivacaine with fenta- 
nyl in the treatment of postoperative pain. Br J Anaesth 1993; 
70:503-7.
lumbar administration. In patients at risk for respira- Mourisse J, Hasenbos MAWM, Gielen MJM, et al. Epidural
A  *  »  Z 1 i  * 1  j  i  i  •  < •  r  .  .  lbupivacaine, sufentanil or the combmation for postthoracotomy 
pain. Acta Anaesthesiol Scand 1992;36:70-4.
12. Dahl JB, Rosenberg J, Hansen BL, et al. Differential analgesic effects 
of low-dose epidural morphine and morphine-bupivacaine after 
major abdominal surgery. Anesth Analg 1992;74:362-5.
13. Hasenbos MAWM, Eckhaus M, Slappendel R, Gielen MJM. 
Continuous high thoracic epidural administration of bupiva­
caine with sufentanil or nicomorphine for postoperative pain 
relief after thoracic surgery. Reg Anesth 1989;14:212-8.
In conclusion, postoperative analgesia for one to 14. Guinard JP, Mavrocordatos P, Chiolero R, Carpenter RL. A
tory depression, we recommend reducing the total 
dose of the opioid by 50%.
Controversy remains regarding whether it is safe to 
administer continuous epidural opioid infusion on  
the ward (2-4). We believe, that with the above- 
mentioned precautions the utility of this technique 
will improve and lead to increased efficacy and safety.
five consecutive days with continuous epidural infu­
sion with sufentanil and bupivacaine w as effective 
both at rest and during m ovem ent in the majority of 
patients after major surgery. Pain relief during m ove­
ment was adequate in around 70% of the patients. Late 
respiratory depression occurred in three 
Most patients experienced only minor side 
Overall technical complications during epidural punc­
ture or insertion of the catheter were 4% and 3%, 
respectively.
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